1 |
Pal S,Lüchtenborg M,Davies EA,et al.Breast cancer in a London population[J].Springerplus,2014,23(3):553.2 李诚,兰莉,杨超.2015—2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J].实用肿瘤学杂志,2019,33(1):62-66.3 Tomao F,Papa A,Zaccarelli E,et al.Triple-negative breast cancer:new perspectives for targeted therapies[J].Onco Targets Ther,2015,16(8):177-193.4 Cleator S,Heller W,Coombes RC.Triple-negative breast cancer:therapeutic options[J].Lancet Oncol,2007,8(3):235-244.5 张丽,赵晓辉,佟仲生,等.356例三阴性乳腺癌的临床特征及预后多因素分析[J].中国肿瘤临床,2010,37(18):1045-1049.6 Brinton LA,,Sherman ME,Carreon JD,et al.Recent trends inbreast cancer among younger women in the United States[J].Natl Cancer Inst,2008,100(22):1643-1648.7 Zhang L,Hao C,Dong G,et al.Analysis of clinical features and outcome of 356 triple-negative breast cancer patients in China[J].Breast Care,2012,7(1):13-17.8 胡一迪,谢粜侠,张辉,等.61例三阴性乳腺癌的临床病理特征及预后因素分析[J].中华内分泌外科杂志,2018,12(2):118-123.9 Goyal S,Puri T,Julka PK,et al.Breast cancer with inguinal node recurrence[J].Egypt Natl Canc Inst,2015,27(1):41-43.10 Linderholm BK,Hellborg H,Johansson U,et a1.Significantly higher levels of vascular endothelial growth factor(VEGF)and shorter survial times for patients with primary operable triple-negative breast cancer[J].Ann Oncol,2009,20:1639-1646.11 余峰,张霄,蓓张晟.三阴性乳腺癌复发特征及危险因素分析[J].中华医学杂志,2014,94(28):2180-2183.12 杜稼苓,李瑞青,陈洁静,等.三阴性乳腺癌临床特征分析[J].中国肿瘤外科杂志,2017,10(9):317-319.13 Han JS,Cao D,Molberg KH,et a1.Hormone receptor status rather than HER2Status is significantly associated with increased Ki-67 and P53 expression in triple-negative breast carcinomas,and high expression of Ki-67 but not P53 is significantly associated with axillary nodal metastasis in triple-negative and high-grade non-triple-negative breast carcinoma[J].Am J Clin Pathol,2011,135(2):230-237.14 Liu C,Zhang Y,Xu H,et al.Girdin protein:a new potential distant metastasis predictor of breast cancer[J].Med Oncol,2012,29(3):1554-1560.15 Lin NU,Vanderplas A,Hughes ME,et al.Clinicopathologic features,patterns of recurrence,and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.Cancer.[J].Cancer,2012,118(22):5463-5472.16 Pogoda K,Niwińska A,Murawska M,et al.Analysis of pattern,time and risk factors influencing recurrence in triple-negative breast cancer patients[J].Med Oncol,2013,30(1):388.17 Bao J,Borja N,Rao M,et al.Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer[J]Cancer Med,2015,4(4):500-506.18 Hébuterne X,Lemari E,Michallet M,et al.Prevalence of malnutrition and current use of nutrition support in patients with cancer[J].JPEN J Parenter Enteral Nutr,2014,38(2):196-204.19 王懋莉,陈宏亮,吴克瑾,等.肥胖对三阴性乳腺癌的临床预后意义[J].中华普通外科杂志,2017,32(10):887-888.20 Kneubil MC,Brollo J,Botteri E,et al.Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction[J].Eur J Surg Oncol,2013,39(3):260-265.
|